Satranidazole

DB19950ExperimentalSmall molecule

Satranidazole is a small molecule drug. The usage of the INN stem '-nidazole' in the name indicates that Satranidazole is a antiprotozoal and radiosensitizer, metronidazole derivative. Satranidazole has a monoisotopic...

Formula / weight: C₈H₁₁N₅O₅S · 289.27 g/mol (avg)

Resolves to

Compound

UNII4N7G8A6439CAS56302-13-7ChEMBLCHEMBL2105542

Clinical / RWD

ATCP01AB08

Structure

InChIKeyFNSHYEAUAUHIMB-UHFFFAOYSA-NSMILESCN1C(=NC=C1[N+]([O-])=O)N1CCN(C1=O)S(C)(=O)=O

What you can answer from here — as of September 20, 2026

1ATC codeIncluding every combination product, plus 5 drug categories

Which companies are running trials of Satranidazole, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account